IN
INNOCAN PHARMA Corp
INNPF · OTC
$1.60 -8.05% (-$0.14)
1M +18.24%
Market Cap $7.20M
P/E Ratio -
Div. Yield -
ROE 13.58%
Piotroski F-Score Weak
3/9Valuation
99 /100
Cheap P/S 0.24x
P/B 1.71x
EV/EBITDA 1.14x
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
22 /100
Weak Net margin 2.21%
Op. margin 1.22%
FCF margin 0.54%
Quality
17 /100
Poor ROE 13.58%
ROA 5.95%
Asset turnover 2.69x
Debt
99 /100
Low Current ratio 3.70x
Int. coverage 126.33x
Net debt/EBITDA -5.00x
Stability
50 /100
Moderate Beta -0.22x
EPS volatility N/A
Profitable years N/A
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre INNPF
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Iris Bincovich
Employees
11
Headquarters
Calgary